tiprankstipranks
Novolog (Pharm UP 1966) Ltd. (IL:NVLG)
TASE:NVLG
Israel Market

Novolog (NVLG) Income Statement

1 Followers

Novolog Income Statement

Last quarter (Q4 2025), Novolog's total revenue was ₪373.25M, a decrease of -45.90% from the same quarter last year. In Q4, Novolog's net income was ₪-5.63M. See Novolog’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
₪ 1.81B₪ 2.02B₪ 1.64B₪ 1.51B₪ 1.26B
Gross Profit
₪ 124.09M₪ 180.78M₪ 173.76M₪ 176.15M₪ 148.96M
Operating Expenses
₪ 97.69M₪ 118.43M₪ 171.11M₪ 97.64M₪ 81.10M
Depreciation and Amortization
₪ 74.36M₪ 78.66M₪ 115.54M₪ 53.49M₪ 45.69M
EBITDA
₪ 100.75M₪ 149.39M₪ 130.14M₪ 138.53M₪ 115.92M
Operating Income
₪ 26.40M₪ 62.35M₪ 2.65M₪ 78.78M₪ 69.94M
Other Income/Expenses
₪ -19.57M₪ -4.66M₪ -922.00K₪ -5.64M₪ -8.17M
Pretax Income
₪ 6.83M₪ 57.68M₪ 1.73M₪ 73.14M₪ 61.77M
Net Income
₪ 4.12M₪ 39.54M₪ -42.00M₪ 47.51M₪ 42.32M
Per Share Metrics
Basic EPS
₪ <0.01₪ 0.08₪ -0.08₪ 0.09₪ 0.08
Diluted EPS
₪ <0.01₪ 0.08₪ -0.08₪ 0.09₪ 0.08
Weighted Average Shares Outstanding
510.85M 510.74M 509.82M 507.27M 505.45M
Weighted Average Shares Outstanding (Diluted)
510.85M 510.74M 510.92M 515.79M 515.08M
Currency in ILS

Novolog Earnings and Revenue History